Clinical implications of p53 alterations in oral cancer progression: a review from India
p53 plays a central role in prevention of normal cell from the development of the malignant phenotype. Somatic alterations (mutations, loss of heterozygosity, deletions) in p53 are a hallmark of most human cancers and cause defects in normal p53 function. However, in the tumors harboring wild-type p...
Збережено в:
Дата: | 2018 |
---|---|
Автори: | , , , , |
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2018
|
Назва видання: | Experimental Oncology |
Теми: | |
Онлайн доступ: | http://dspace.nbuv.gov.ua/handle/123456789/139242 |
Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
Цитувати: | Clinical implications of p53 alterations in oral cancer progression: a review from India / K.R. Patel, B.N. Vajaria, R.D. Singh, R. Begum, P.S. Patel // Experimental Oncology. — 2018 — Т. 40, № 1. — С. 10–18. — Бібліогр.: 90 назв. — англ. |
Репозитарії
Digital Library of Periodicals of National Academy of Sciences of Ukraineid |
irk-123456789-139242 |
---|---|
record_format |
dspace |
spelling |
irk-123456789-1392422018-06-22T16:07:55Z Clinical implications of p53 alterations in oral cancer progression: a review from India Patel, K.R. Vajaria, B.N. Singh, R.D. Begum, R. Patel, P.S. Reviews p53 plays a central role in prevention of normal cell from the development of the malignant phenotype. Somatic alterations (mutations, loss of heterozygosity, deletions) in p53 are a hallmark of most human cancers and cause defects in normal p53 function. However, in the tumors harboring wild-type p53, there are alterations in the regulation of the p53. Thus, understanding why p53 is unable to perform its role as a tumor suppressor in these wild-type tumors is very crucial. Germ-line polymorphisms in p53 are also anticipated to cause measurable disturbance in p53 function. Over-expression as well as polymorphic variants of MDM2 might have effects on cancer development. In addition, degradation of p53 by E6 protein of high risk human papillomavirus is also suggested as one of the mechanisms which attenuate p53 responses in oral carcinogenesis. p53 has also been demonstrated to mediate cellular responses upon various DNA damaging cancer therapies, importantly, apoptosis. These responses have been implicated in an individual’s ability to respond to these cancer therapies. Thus, exploring mechanisms by which normal function of p53 is affected in the comprehensive way in oral cancer might aid in the identification of tumor characteristics, prognosis and thus in the development of a new approach to treat the oral cancer. 2018 Article Clinical implications of p53 alterations in oral cancer progression: a review from India / K.R. Patel, B.N. Vajaria, R.D. Singh, R. Begum, P.S. Patel // Experimental Oncology. — 2018 — Т. 40, № 1. — С. 10–18. — Бібліогр.: 90 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/139242 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
institution |
Digital Library of Periodicals of National Academy of Sciences of Ukraine |
collection |
DSpace DC |
language |
English |
topic |
Reviews Reviews |
spellingShingle |
Reviews Reviews Patel, K.R. Vajaria, B.N. Singh, R.D. Begum, R. Patel, P.S. Clinical implications of p53 alterations in oral cancer progression: a review from India Experimental Oncology |
description |
p53 plays a central role in prevention of normal cell from the development of the malignant phenotype. Somatic alterations (mutations, loss of heterozygosity, deletions) in p53 are a hallmark of most human cancers and cause defects in normal p53 function. However, in the tumors harboring wild-type p53, there are alterations in the regulation of the p53. Thus, understanding why p53 is unable to perform its role as a tumor suppressor in these wild-type tumors is very crucial. Germ-line polymorphisms in p53 are also anticipated to cause measurable disturbance in p53 function. Over-expression as well as polymorphic variants of MDM2 might have effects on cancer development. In addition, degradation of p53 by E6 protein of high risk human papillomavirus is also suggested as one of the mechanisms which attenuate p53 responses in oral carcinogenesis. p53 has also been demonstrated to mediate cellular responses upon various DNA damaging cancer therapies, importantly, apoptosis. These responses have been implicated in an individual’s ability to respond to these cancer therapies. Thus, exploring mechanisms by which normal function of p53 is affected in the comprehensive way in oral cancer might aid in the identification of tumor characteristics, prognosis and thus in the development of a new approach to treat the oral cancer. |
format |
Article |
author |
Patel, K.R. Vajaria, B.N. Singh, R.D. Begum, R. Patel, P.S. |
author_facet |
Patel, K.R. Vajaria, B.N. Singh, R.D. Begum, R. Patel, P.S. |
author_sort |
Patel, K.R. |
title |
Clinical implications of p53 alterations in oral cancer progression: a review from India |
title_short |
Clinical implications of p53 alterations in oral cancer progression: a review from India |
title_full |
Clinical implications of p53 alterations in oral cancer progression: a review from India |
title_fullStr |
Clinical implications of p53 alterations in oral cancer progression: a review from India |
title_full_unstemmed |
Clinical implications of p53 alterations in oral cancer progression: a review from India |
title_sort |
clinical implications of p53 alterations in oral cancer progression: a review from india |
publisher |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
publishDate |
2018 |
topic_facet |
Reviews |
url |
http://dspace.nbuv.gov.ua/handle/123456789/139242 |
citation_txt |
Clinical implications of p53 alterations in oral cancer progression: a review from India / K.R. Patel, B.N. Vajaria, R.D. Singh, R. Begum, P.S. Patel // Experimental Oncology. — 2018 — Т. 40, № 1. — С. 10–18. — Бібліогр.: 90 назв. — англ. |
series |
Experimental Oncology |
work_keys_str_mv |
AT patelkr clinicalimplicationsofp53alterationsinoralcancerprogressionareviewfromindia AT vajariabn clinicalimplicationsofp53alterationsinoralcancerprogressionareviewfromindia AT singhrd clinicalimplicationsofp53alterationsinoralcancerprogressionareviewfromindia AT begumr clinicalimplicationsofp53alterationsinoralcancerprogressionareviewfromindia AT patelps clinicalimplicationsofp53alterationsinoralcancerprogressionareviewfromindia |
first_indexed |
2023-10-18T21:19:23Z |
last_indexed |
2023-10-18T21:19:23Z |
_version_ |
1796152506438385664 |